
Q-Line Biotech IPO GMP
NSE EmergeListedHealthcare Service Provider · Listed on NSE · 21 May 2026 - 25 May 2026
Jagat JoshiQ-Line Biotech IPO GMP is ₹129 updated as of 29-May-2026 12:00 PM. The estimated listing gain for Q-Line Biotech is 37.61% with an estimated profit of ₹51,600 per applied lot. Based on the latest GMP, the IPO may list at ₹472.
Q-Line Biotech GMP touched a high of ₹130 on 23 May 2026, while the lowest GMP of ₹65 was recorded on 18 May 2026.
The GMP is available with historical trend, estimated listing price and day-wise grey market movement. The IPO GMP is an unofficial indicator that reflects investor-market sentiment, and demand for an IPO in unofficial market before listing. However, it may fluctuate based on investor demand, market conditions and overall sentiment.
The IPO GMP and estimated listing price mentioned on this page are provided for informational and educational purposes only. The grey market is unofficial and unregulated and can change without notice.
We do not buy or sell IPO applications in the grey market. Investors should not subscribe to an IPO based on GMP. Please do your own research and consider the company’s fundamentals, financial information, valuation, and risk factors before investing in an IPO.
Stock market investments are subject to market risks. Please read all offer-related documents carefully before investing.

Join the discussion
Please sign in to leave a comment or reply.